Effect of Low-Dose Nitroglycerin on Acute Respiratory Distress Syndrome in Elderly Patients after Major Surgery: A Randomized Controlled Trial
This randomized controlled trial demonstrates that intraoperative continuous infusion of low-dose nitroglycerin significantly reduces the incidence of postoperative acute respiratory distress syndrome (ARDS) in elderly patients undergoing major surgery, particularly benefiting those who are very elderly, high-risk, or undergoing major abdominal laparoscopic procedures.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person undergoes a major operation, the body often mounts a fierce, sometimes overwhelming, defense against the trauma. In the lungs, this defense can sometimes turn destructive, leading to a condition called acute respiratory distress syndrome. This is a severe state where the air sacs in the lungs fill with fluid, making it nearly impossible for oxygen to pass into the blood. The problem is particularly dangerous for older adults, whose bodies are less able to recover from such stress. While doctors have long known how to support patients once this condition sets in, finding a way to prevent it from happening in the first place has remained one of the most difficult challenges in modern medicine. For decades, researchers have tested various drugs and strategies, hoping to find a simple intervention that could stop the lungs from failing, but effective solutions have been scarce.
In a recent study conducted at a major hospital in China, a team of anesthesiologists explored a different approach using a common medication known for decades. Nitroglycerin is a drug most people recognize as a treatment for chest pain, where it works by relaxing blood vessels to improve blood flow. The researchers wondered if this same relaxing effect, when delivered slowly and carefully during surgery, could protect the lungs of elderly patients from the inflammation that leads to respiratory failure. They focused on a specific group: older adults undergoing major elective surgery who were expected to spend time in the intensive care unit afterward. The question was straightforward: could a steady, low-level infusion of this drug during the operation act as a shield, keeping the lungs clear and functional when the body is under the most stress?
To find the answer, the team enrolled 214 elderly patients who met strict criteria for major surgery. The patients were divided into two groups. One group received a standard saline solution through an intravenous line, while the other received the same saline mixed with a small, continuous dose of nitroglycerin. The infusion began as soon as the surgery started and stopped when the procedure was finished. Throughout the operation and the recovery period, the medical team closely monitored the patients' breathing, blood pressure, and oxygen levels, looking for any signs that the lungs were struggling. The study was designed so that the doctors caring for the patients after surgery did not know which group the patients belonged to, ensuring that their observations remained unbiased.
The results offered a clear signal. Within the first week after surgery, the patients who received the nitroglycerin infusion developed acute respiratory distress syndrome at a significantly lower rate than those who did not. Specifically, about 9 percent of the treated patients developed the condition, compared to roughly 21 percent of the untreated patients. This difference was not a fluke; it held true even when the researchers looked at specific subgroups of patients, such as those over the age of 75, those with high blood pressure, or those undergoing abdominal surgery. The treated patients also showed better oxygen levels in their blood at the end of the operation, suggesting that the drug helped the lungs exchange air more effectively while the body was under the stress of anesthesia and surgical trauma.
However, the story is not one of a complete cure-all. While the drug successfully prevented the onset of the most severe lung injury, it did not change the length of time patients needed to stay in the hospital, the duration of their time in the intensive care unit, or their overall survival rates in the months following the surgery. The researchers noted that the drug had very little effect on the patients' blood pressure, indicating that the protective benefit came from a specific mechanism in the lungs rather than a general change in circulation. They also acknowledged that the study was conducted at a single location, which means the findings might need to be confirmed in other settings with different patient populations.
The study suggests that for elderly patients facing major surgery, a continuous infusion of low-dose nitroglycerin during the operation can serve as a protective measure against a devastating lung complication. It appears to work by keeping the blood vessels in the lungs relaxed and improving the flow of air and blood, effectively reducing the inflammation that typically triggers the syndrome. While it does not guarantee a shorter hospital stay or a faster recovery for every individual, it offers a tangible way to lower the risk of one of the most serious postoperative complications. For the very elderly and those with existing health conditions, this simple intervention during the critical hours of surgery could mean the difference between a difficult recovery and a manageable one.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.